Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?

被引：11
|
作者：
Samos, Matej [1 ]
Fedor, Marian [2 ]
Kovar, Frantisek [1 ]
Duraj, Lukas [2 ]
Stanciakova, Lucia [2 ]
Galajda, Peter [1 ]
Stasko, Jan [2 ]
Kubisz, Peter [2 ]
Mokan, Marian [1 ]
机构：
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Internal Med 1, Kollarova 2, Martin 03659, Slovakia
[2] Comenius Univ, Jessenius Fac Med Martin, Dept Hematol & Blood Transfus, Natl Ctr Hemostasis & Thrombosis, Martin 03659, Slovakia
来源：
BLOOD COAGULATION & FIBRINOLYSIS | 2016年 / 27卷 / 02期
关键词：
high on-treatment platelet reactivity; percutaneous coronary intervention; stent thrombosis; ticagrelor; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; PRASUGREL; PRETREATMENT; EFFICACY; IMPACT;
D O I：
10.1097/MBC.0000000000000406
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Stent thrombosis is a morbid complication following percutaneous coronary intervention (PCI). Dual antiplatelet therapy significantly reduces stent thrombosis risk. However, the antiplatelet response to clopidogrel - the most frequently used ADP receptor antagonist in post-PCI patients - varies among individuals. High on-treatment platelet reactivity was repeatedly associated with the risk of stent thrombosis. Ticagrelor is a novel ADP receptor blocker that has shown greater, more rapid and more consistent platelet inhibition than clopidogrel. This agent offers a unique mechanism of action, no relevant pharmacological interactions, consistent platelet inhibition, and a good safety profile. This article reviews the prospective use of ticagrelor in the treatment of stent thrombosis in acute coronary syndrome patients undergoing PCI of culprit coronary lesion. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码：117 / 120
页数：4
相关论文
共 50 条
  • [31] A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite
    von Beckerath, N
    Taubert, D
    Pogatsa-Murray, G
    Wieczorek, A
    Schömig, E
    Schömig, A
    Kastrati, A
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) : 789 - 791
  • [32] Combined aspirin and Clopidogrel resistance associated with recurrent coronary stent thrombosis
    Templin C.
    Schaefer A.
    Stumme B.
    Drexler H.
    Von Depka M.
    Clinical Research in Cardiology, 2006, 95 (2) : 122 - 126
  • [33] Recurrent coronary stent thrombosis in a patient with combined aspirin and clopidogrel resistance
    Templin, C
    Schaefer, A
    Stumme, B
    Drexler, H
    Prondzinski, MV
    35th Hemophilia Symposium, 2006, : 235 - 238
  • [34] Effects of genetic factors to stent thrombosis due to clopidogrel resistance after coronary stent placement
    Kirac, D.
    Erdem, A.
    Avcilar, T.
    Yesilcimen, K.
    Guney, A. I.
    Emre, A.
    Yazici, S.
    Terzi, S.
    Kaspar, E. C.
    Cetin, S. E.
    Isbir, T.
    CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (01) : 51 - 55
  • [35] Optimalized individual antiplatelet therapy in high risk cardiovascular patients with coronary stent thrombosis and clopidogrel resistance
    Zsamboki, E. Toth
    Beres, B. J.
    Vargova, K.
    Bencze, J.
    Kerecsen, G.
    Csoti, E.
    Preda, I.
    Kiss, R. G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 752 - 752
  • [36] Clopidogrel pharmacogenetics: associations between genotype and stent thrombosis risk in patients with stent placement
    Ferrari, Marco
    Tozzi, Matteo
    Marino, Franca
    Tarallo, Antonio
    Riva, Francesca
    Mirabile, Mauro
    Castelli, Patrizio
    Cosentino, Marco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2019, 20 (01) : 46 - 48
  • [37] Suspected clopidogrel resistance associated with recurrent coronary stent thrombosis - a case report
    Tomaszuk-Kazberuk, Anna
    Sobkowicz, Bozena
    Usowicz-Szarynska, Monika
    Prokop, Jolanta B.
    Knapp, Matgorzata
    Sawicki, Robert
    Musial, Wlodzimierz J.
    KARDIOLOGIA POLSKA, 2007, 65 (07) : 810 - 816
  • [38] The Clopidogrel Resistance in Stent Thrombosis (CREST) Registry: The Case for Personalized Antiplatelet Therapy?
    Sambu, Nalyaka
    Radhakrishnan, Ashwin
    Dent, Hazel
    Calver, Alison
    Corbett, Simon
    Gray, Huon
    Simpson, Iain
    Curzen, Nick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B23 - B23
  • [39] Subacute Stent Thrombosis Owing to Complete Clopidogrel Resistance Successfully Managed with Prasugrel
    Flaherty, Michael P.
    Johnston, Peter V.
    Rade, Jeffrey J.
    JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (07): : 300 - 304
  • [40] Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis
    Samos, Matej
    Simonova, Radoslava
    Kovar, Frantisek
    Duraj, Lukas
    Fedorova, Jana
    Galajda, Peter
    Stasko, Jan
    Fedor, Marian
    Kubisz, Peter
    Mokan, Marian
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2014, 32 (05): : 461 - 465
12345